Urorec® (silodosin) Capsules

From 1 July 2020, UROREC (silodosin) is available on the Repatriation Schedule of Pharmaceutical Benefits (RPBS).

For information on the RPBS listing click here

For additional safety and other information, please see Product information

For additional consumer information, please see Consumer Medicine Information

The following digital patient resources are available:

Bladder diary                                         International Prostate Symptom Score (I-PSS)